"
Team:Tsinghua
From 2014.igem.org
(Difference between revisions)
| (2 intermediate revisions not shown) | |||
| Line 3: | Line 3: | ||
{{Team:Tsinghua/css/jquery-1.10.1.min.js}} | {{Team:Tsinghua/css/jquery-1.10.1.min.js}} | ||
<html> | <html> | ||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
<body onload=' location.href="#anchor1" '> | <body onload=' location.href="#anchor1" '> | ||
<div class="container"> | <div class="container"> | ||
| Line 18: | Line 13: | ||
</div> | </div> | ||
<div id="text1" class="slideLeft"> | <div id="text1" class="slideLeft"> | ||
| - | <h1 class="customtext | + | <h1 class="customtext">Hi! We are <font color="990099">Team Tsinghua</font>. We present to you a <font color="990099">gene therapy</font> for Type 1 Diabetes Mellitus (T1DM).</h1> |
</div> | </div> | ||
</span> | </span> | ||
Latest revision as of 18:20, 15 October 2014
T1DM results from autoimmune destruction of pancreatic beta cells. Our approach converts somatic cells into regulated insulin-producing cells, thus eliminating the need for continuous insulin therapy.
Scroll down
We use Adeno-associated virus (AAV) as a transfection vector to introduce genes, which has proven to be safe… Well, that’s a whole other story, want to know more?
Scroll down
